1596 related articles for article (PubMed ID: 7999456)
1. Sex steroids and breast cancer prevention.
Spicer DV; Pike MC
J Natl Cancer Inst Monogr; 1994; (16):139-47. PubMed ID: 7999456
[TBL] [Abstract][Full Text] [Related]
2. The prevention of breast cancer through reduced ovarian steroid exposure.
Spicer DV; Pike MC
Acta Oncol; 1992; 31(2):167-74. PubMed ID: 1622631
[TBL] [Abstract][Full Text] [Related]
3. Epidemiologic aspects of exogenous progestagens in relation to their role in pathogenesis of human breast cancer.
van Leeuwen FE
Acta Endocrinol (Copenh); 1991; 125 Suppl 1():13-26. PubMed ID: 1801500
[TBL] [Abstract][Full Text] [Related]
4. The chemoprevention of breast cancer by reducing sex steroid exposure: perspectives from epidemiology.
Pike MC; Spicer DV
J Cell Biochem Suppl; 1993; 17G():26-36. PubMed ID: 8007706
[TBL] [Abstract][Full Text] [Related]
5. Does HRT modify risk of gynecological cancers?
Schneider HP; Birkhauser M
Int J Fertil Menopausal Stud; 1995; 40 Suppl 1():40-53. PubMed ID: 7581588
[TBL] [Abstract][Full Text] [Related]
6. Hormone replacement therapy and cancer.
Gynecol Endocrinol; 2001 Dec; 15(6):453-65. PubMed ID: 11826770
[TBL] [Abstract][Full Text] [Related]
7. [Cancer risk under hormone therapy].
Lauritzen C
Ther Umsch; 1994 Nov; 51(11):755-66. PubMed ID: 7839334
[TBL] [Abstract][Full Text] [Related]
8. Controversial issues in climacteric medicine II. Hormone replacement therapy and cancer. International Menopause Society Expert Workshop. 9-12 June 2001, Opera del Duomo, Pisa, Italy.
Genazzani AR; Gadducci A; Gambacciani M
Climacteric; 2001 Sep; 4(3):181-93. PubMed ID: 11588941
[TBL] [Abstract][Full Text] [Related]
9. Contraception and the big "C".
Chandran R
Malays J Reprod Health; 1992 Jun; 10(1):1-5. PubMed ID: 12345024
[TBL] [Abstract][Full Text] [Related]
10. [The present state of research on the relationship of oral contraceptives to breast cancer].
Pike MC
Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):329-38. PubMed ID: 12280203
[TBL] [Abstract][Full Text] [Related]
11. Use of HRT and the subsequent risk of cancer.
Beral V; Banks E; Reeves G; Appleby P
J Epidemiol Biostat; 1999; 4(3):191-210; discussion 210-5. PubMed ID: 10695959
[TBL] [Abstract][Full Text] [Related]
12. [Oral contraception and its beneficial gynecological effects].
Belaisch J; Hommais-loufrani B
Fertil Contracept Sex; 1988 Mar; 16(3 Suppl):3-7. PubMed ID: 12282188
[TBL] [Abstract][Full Text] [Related]
13. The risk of breast, endometrial and ovarian cancer in users of hormonal preparations.
Bernstein L
Basic Clin Pharmacol Toxicol; 2006 Mar; 98(3):288-96. PubMed ID: 16611204
[TBL] [Abstract][Full Text] [Related]
14. Contraception for the perimenopausal patient.
Upton GV
Obstet Gynecol Clin North Am; 1987 Mar; 14(1):207-27. PubMed ID: 3306520
[TBL] [Abstract][Full Text] [Related]
15. An appraisal of strategies to reduce the incidence of breast cancer.
Jordan VG; Morrow M
Stem Cells; 1993 Jul; 11(4):252-62. PubMed ID: 8401248
[TBL] [Abstract][Full Text] [Related]
16. Effects of sex steroids on proliferation in normal mammary tissue.
Söderqvist G
Ann Med; 1998 Dec; 30(6):511-24. PubMed ID: 9920352
[TBL] [Abstract][Full Text] [Related]
17. The rationale for a wider range of progestogens.
Skouby SO
Climacteric; 2000 Dec; 3 Suppl 2():14-20. PubMed ID: 11379382
[TBL] [Abstract][Full Text] [Related]
18. Pilot trial of a gonadotropin hormone agonist with replacement hormones as a prototype contraceptive to prevent breast cancer.
Spicer DV; Pike MC; Pike A; Rude R; Shoupe D; Richardson J
Contraception; 1993 May; 47(5):427-44. PubMed ID: 8390340
[TBL] [Abstract][Full Text] [Related]
19. Hormones and breast cancer.
ESHRE Capri Workshop Group
Hum Reprod Update; 2004; 10(4):281-93. PubMed ID: 15192054
[TBL] [Abstract][Full Text] [Related]
20. Breast cancer risk during hormone therapy: experimental versus clinical data.
Ruan X; Seeger H; Mueck AO
Minerva Endocrinol; 2012 Mar; 37(1):59-74. PubMed ID: 22382615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]